Characterization of G2P rotavirus strains associated with increased detection in Australian states using the RotaTeq (R) vaccine during the 2010-2011 surveillance period
Celeste M Donato, Zheng Andrew Zhang, Nicole C Donker, Carl D Kirkwood
Infection, Genetics and Evolution | ELSEVIER | Published : 2014
Awarded by National Health and Medical Research Council of Australia
C.D. Kirkwood is director of Australian Rotavirus Surveillance Program, which is supported by research grants from vaccine manufacturers CSL, GSK and Merck. This work was supported by grants from the National Health and Medical Research Council of Australia ; Australian Commonwealth Department of Health; GSK Biologicals (Melbourne, Australia); and CSL (Melbourne, Australia). C.D. Kirkwood is supported by a Career Development Award from the National Health and Medical Research Council of Australia . This study was supported by the Victorian Government's Operational Infrastructure Support Program.